Sodium 1-((6-(3-(3-methyl-3H-diazirin-3-yl)propanamido)hexanoyl)oxy)-2,5-dioxopyrrolidine-3-sulfonate

Catalog No. :
ACJUAG473
CAS No. :
1909307-62-5
Molecular Formula :
C15H21N4NaO8S
Molecular Weight :
440.41

IUPAC Name:sodium 1-((6-(3-(3-methyl-3H-diazirin-3-yl)propanamido)hexanoyl)oxy)-2,5-dioxopyrrolidine-3-sulfonate

Sodium 1-((6-(3-(3-methyl-3H-diazirin-3-yl)propanamido)hexanoyl)oxy)-2,5-dioxopyrrolidine-3-sulfonate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameSodium 1-((6-(3-(3-methyl-3H-diazirin-3-yl)propanamido)hexanoyl)oxy)-2,5-dioxopyrrolidine-3-sulfonate
IUPAC Namesodium 1-((6-(3-(3-methyl-3H-diazirin-3-yl)propanamido)hexanoyl)oxy)-2,5-dioxopyrrolidine-3-sulfonate
Molecular FormulaC15H21N4NaO8S
Molecular Weight440.41
SMILESO=C(ON1C(C(S(=O)([O-])=O)CC1=O)=O)CCCCCNC(CCC2(C)N=N2)=O.[Na+]
InChI KeyNZJSKWCJBUEDEO-UHFFFAOYSA-M
SynonymSulfo-LC-SDA;Sulfo-LC-SDA(Sulfo-NHS-LC-Diazirine) (sulfosuccinimidyl 6-(4,4'-azipentanamido)hexanoate)
CAS No.1909307-62-5

Safety Data

Pictogram
FlammableHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H228-H315-H319
Precautionary Statement(s)
P210-P240-P241-P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P370+P378

Synthetic Route by SureRoute

1. ACJUAG473 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEXAU316 route compound structure diagram
    ACEXAU31625055-86-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJUAG473 route product structure diagram
    ACJUAG4731909307-62-5
Inquiry

2. ACJUAG473 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJUAG473 route product structure diagram
    ACJUAG4731909307-62-5
Inquiry

Comments (0)